Cancer epidemiology in Central, South, and Eastern European countries

Vrdoljak, Eduard; Wojtukiewicz, Marek Z.; Pienkowski, Tadeusz; Bodoky, Gyorgy; Berzinec, Peter; Finek, Jindrich; Todorović, Vladimir; Borojević, Nenad; Croitoru, Adina
August 2011
Croatian Medical Journal;Aug2011, Vol. 52 Issue 4, p478
Academic Journal
Aim To collect cancer epidemiology data in South Eastern European countries as a basis for potential comparison of their performance in cancer care. Methods The South Eastern European Research Oncology Group (SEEROG) collected and analyzed epidemiological data on incidence and mortality that reflect cancer management in 8 countries - Croatia, Czech Republic, Hungary, Romania, Poland, Slovakia, and Serbia and Montenegro in the last 20-40 years. Results The most common cancer type in men in all countries was lung cancer, followed by colorectal and prostate cancer, with the exception of the Czech Republic, where prostate cancer and colorectal cancer were more common. The most frequent cancer in women was breast cancer followed by colorectal cancer, with the exceptions of Romania and Central Serbia where cervical cancer was the second most common. Cancer mortality data from the last 20-40 years revealed two different patterns in men. In Romania and in Serbia and Montenegro, there was a trend toward an increase, while in the other countries mortality was declining, after increasing for a number of years. In women, a steady decline was observed over many years in the Czech Republic, Hungary, and Slovakia, while in the other countries it remained unchanged. Conclusions There are striking variations in the risk of different cancers by geographic area. Most of the international variation is due to exposure to known or suspected risk factors which provides a clear challenge to prevention. There are some differences in incidence and mortality that cannot be explained by exposure to known risk factors or treatment availabilities.


Related Articles

  • Cancer screening tests every doctor should do. Frame, Paul S. // Cortlandt Forum;Feb2006, Vol. 19 Issue 2, p67 

    The article reports on cancer screening tests, which is an integral part of every cancer preventive protocol. Cancer screening is recommended for breast, cervical, colorectal and prostate cancer. The U.S. Preventive Services Task Force (USPTF) and the American Cancer Society have endorsed...

  • Updates in colon, cervical, breast, and prostate cancer screening. Smith, Robert A.; Standiford, Connie J.; Saraiya, Mona // Patient Care for the Nurse Practitioner;Sep2005, Vol. 8 Issue 9, p7 

    The article states that the reported benefits of cancer screening, a large subset of the population continues to go unscreened or is screened inconsistently. Doctors and nurse practitioners can make a huge difference in this area by recommending testing and raising patient awareness about the...

  • Sharpton teams up with Ralph Lauren Center.  // New York Amsterdam News;8/28/2008, Vol. 99 Issue 36, p9 

    The article reports on the collaborative efforts of Reverend Al Sharpton and the Ralph Lauren Center for Cancer Care and Prevention (RLCCCP) in organizing the Second Annual Harlem's Cancer Screening Campaign in New York. Sharpton claims that their main objective in the campaign is to have more...

  • Dijagnostički algoritam kod bolesnika sa cervikalnirm metastazama malignih tumora nepoznate primarrie lokalizacije. Krejović-Trivić, S. B.; Trivić, A. S.; Banko, A. V.; Milovanović, A. P.; Ugrinović, A. B.; Vukašinović, M. // Acta Chirurgica Iugoslavica;2009, Vol. 56 Issue 3, p17 

    Carcinoma of unknown primary location are heterogeneous group of metastatic tumours where primary location could not b~ discovered with detail anamnesis, clinical examination and diagnostic procedures. Patients with metastasis carcinoma of unknown primary location in clinical oncology are...

  • Cancer's Impact on South Dakotans. Huber, Thomas J. // South Dakota Medicine;2010, p3 

    The author encourages readers to consider issues on breast, lung, prostate and colorectal cancer in South Dakota.

  • Papillomavirus from the Bench to the Clinics. Filho, Adhemar Longatto; Villa, Luisa Lina; Syrjänen, Kari // Journal of Oncology;2012, p1 

    The author reflects on a virus called Human papillomavirus which becomes the primary cause for uterine cervical, prostate, and breast cancers.

  • High risk genes predisposing to prostate cancer development–do they exist? Singh, R; Eeles, R A; Durocher, F; Simard, J; Edwards, S; Badzioch, M; Kote-Jarai, Z; Teare, D; Ford, D; Dearnaley, D; Ardern-Jones, A; Murkin, A; Dowe, A; Shearer, R; Kelly, J; Labrie, F; Easton, D; Narod, S A; Tonin, P N // Prostate Cancer & Prostatic Diseases;2000, Vol. 3 Issue 4, p241 

    There is evidence for genetic predisposition to prostate cancer. However, prostate cancer genes have been more difficult to find than genes for some of the other common cancers, such as breast and colon cancer. The reasons for this are discussed in this article and it is now becoming clear that...

  • Semi-automated quantification of living cells with internalized nanostructures. Margineanu, Michael Bogdan; Julfakyan, Khachatur; Sommer, Christoph; Perez, Jose Efrain; Contreras, Maria Fernanda; Khashab, Niveen; Kosel, Jürgen; Ravasi, Timothy // Journal of Nanobiotechnology;1/15/2016, Vol. 14, p1 

    Background: Nanostructures fabricated by different methods have become increasingly important for various applications in biology and medicine, such as agents for medical imaging or cancer therapy. In order to understand their interaction with living cells and their internalization kinetics,...

  • Functional localization and competition between the androgen receptor and T-cell factor for nuclear ß-catenin: a means for inhibition of the Tcf signaling axis. Mulholland, David J; Read, Jason T; Rennie, Paul S; Cox, Michael E; Nelson, Colleen C // Oncogene;8/28/2003, Vol. 22 Issue 36, p5602 

    Recent reports suggest that the ß-catenin-T-cell factor (Tcf) (BCT) signaling pathway is important in the progression of prostate cancer. Evidence suggests that the androgen receptor (AR) can repress BCT-mediated transcription both in prostate cancer and colon cancer cells (Chesire and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics